Red blood cells are responsible for performing one of the crucial tasks. They usually carry oxygen from the lungs to the tissues throughout the body. They may also remove carbon dioxide and support your organs to function normally. While red blood cells are not part of your immune system, researchers might have discovered a role for red blood cells in cancer care. Their unique properties are now being studied to fight against cancer.
How can red blood cells fight cancer?
Red blood cells can travel safely through your bloodstream for longer periods without triggering any immune response. It's due to this nature that red blood cells can be loaded with anti-cancer drugs, which can deliver medicine precisely into tumors. This way, it can reduce the damage to your surrounding healthy tissues, making it more personalized. Also, they may support your immune system by interacting with your immune cells and can remove cancerous substances from your bloodstream.
What does research have to say about it?
Engineered red blood cells are now changing from just basic laboratory prototypes to a versatile clinical platform. These platforms can now be used for advanced drug delivery, targeted cancer immunotherapy, and custom blood transfusion. A study published by Science Direct in May 2025 talks about red blood cells being derived as biomimetic components. Another study published by the National Library of Medicine in August 2023 talks clearly about how red blood cells can be used for T-cell activation. Although many of these studies are still in clinical trials, they represent a promising future of personalized cancer treatment.
Potential benefits and challenges
Just like other cancer therapies, red blood cell-based therapies also have their own potential merits and demerits.
Benefits:
Can deliver anti-cancer drugs directly into tumors
Circulate for a longer period in the bloodstream
Reduces damage to surrounding healthy tissues
May improve the effectiveness of other therapies like immunotherapy
Challenges:
Many red blood cell approaches are still under study
Engineering red blood cells remains challenging
Further evaluation may be needed for long-term safety
What does this mean for the future?
Although red blood cell therapies are still not considered standard cancer treatments, they are showing hopeful results. With their ability to deliver medicines precisely, it is clear that they can be a more effective and safer approach. While clinical trials are still needed to confirm this, these therapies are surely going to be an important tool for the next generation of personalized cancer treatments.